PROVIDER PROFILE · NPI 1902844210

Felix UrmanM.D.

PRACTICEACADEMIC DERMATOLOGY INCSee all providers at this practice →

DermatologySomerset, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

418

Unique beneficiaries

—

Total services

649

Distinct HCPCS

Medicare payment

$17K

Peer benchmark

Total Medicare services vs. 360 Dermatology providers in NJ — bottom quintile (cohort median 2,586).

PRESCRIBING · PART D · 2024

Total Rx claims

277

Beneficiaries

—

Total drug cost

$14K

Distinct drugs

Brand share

11.2%

Top prescribed drugs

Clobetasol Propionate95 claims

Triamcinolone Acetonide36 claims

Ciclopirox Olamine31 claims

Mupirocin23 claims

Fluorouracil21 claims

QUALITY · MIPS · 2024

Final MIPS score

82.7

Quality

71.8

Cost

70.7

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.33%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Felix Urman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	71	246
SAINT PETER'S UNIVERSITY HOSPITAL	33	80
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	27	36
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL, INC	26	82
Joy Kim Podiatry · North Brunswick, NJ	12	19

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history